Professional Documents
Culture Documents
SWigati AnatKel Endo
SWigati AnatKel Endo
KERJA
HORMON
TIROID
PADA
SEL TARGET
MEKANISME
KERJA
HORMON
STEROID
PADA
SEL TARGET
CONTOH KERJA HORMON PEPTIDA
POSISI GLANDULA PITUITARY
GLANDULA PITUITARY
HORMON ANTERIOR PITUITARY
HORMON POSTERIOR PITUITARY
HUBUNGAN ANTARA HIPOTALAMUS
DENGAN ANTERIOR PITUITARY
HUBUNGAN ANTARA HIPOTALAMUS
DENGAN POSTERIOR PITUITARY
HUBUNGAN HIPOTALAMUS –
PITUITARY - GONAD
GLANDULA PARATIROID
HORMON
PARATIROID
MEKANISME KONTROL SINTESIS VIT. D
Keton darah
Filtrasi ginjal untk gula dan
keton
H+ darah
Osmotic diuresis (acidosis)
Excresi natrium
dan air
Tekanan darah
The ovaries are small, paired organs that are located near the lateral
walls of the pelvic cavity. These organs are responsible for the
production of the ova and the secretion of hormones. Ovaries are the
place inside the female body where ova or eggs are produced. The
process by which the ovum is released is called ovulation. The speed
of ovulation is periodic and impacts directly to the length of a
menstrual cycle.
The testes and ovaries become briefly inactive around the time
of birth but resume hormonal activity until several months
after birth, when incompletely understood mechanisms in the
brain begin to suppress the activity of the arcuate nucleus.
This has been referred to as maturation of the prepubertal
"gonadostat," which becomes sensitive to negative feedback
by sex steroids.
STRUCTURE
Activin is a dimer composed of two identical or very similar
beta subunits.
In males
It is secreted from the Sertoli cells,[18] located in the seminiferous tubules
inside the testes. Androgens stimulate inhibin production; this protein may
also help to locally regulate spermatogenesis.[citation needed]
Mechanism of action
Activin
As with other members of the superfamily, activins interact with two
types of cell surface transmembrane receptors (Types I and II) which
have intrinsic serine/threonine kinase activities in their cytoplasmic
domains:
Activin type 1 receptors: ACVR1, ACVR1B, ACVR1C
Activin type 2 receptors: ACVR2A, ACVR2B
Activin binds to the Type II receptor and initiates a cascade reaction
that leads to the recruitment, phosphorylation, and activation of Type
I activin receptor. This then interacts with and then phosphorylates
SMAD2 and SMAD3, two of the cytoplasmic SMAD proteins.
Smad3 then translocates to the nucleus and interacts with SMAD4
through multimerization, resulting in their modulation as
transcription factor complexes responsible for the expression of a
large variety of genes.
Inhibin
In contrast to activin, much less is known about the mechanism of
action of inhibin, but may involve competing with activin for binding
to activin receptors and/or binding to inhibin-specific receptors. [8]
Clinical significance
Quantification of inhibin A is part of the prenatal quad screen that
can be administered during pregnancy at a gestational age of 16–18
weeks. An elevated inhibin A (along with an increased beta-hCG,
decreased AFP, and a decreased estriol) is suggestive of the
presence of a fetus with Down syndrome.[19] As a screening test,
abnormal quad screen test results need to be followed up with more
definitive tests.
It also has been used as a marker for ovarian cancer.[20][21]
Inhibin B may be used as a marker of spermatogenesis function and
male infertility.
The mean serum inhibin B level is significantly higher among fertile
men (approximately 140 pg/mL) than in infertile men (approximately
80 pg/mL).[22] In men with azoospermia, a positive test for inhibin B
slightly raises the chances for successfully achieving pregnancy
through testicular sperm extraction (TESE), although the association
is not very substantial, having a sensitivity of 0.65 (95% confidence
interval [CI]: 0.56–0.74) and a specificity of 0.83 (CI: 0.64–0.93) for
prediction the presence of sperm in the testes in non-obstructive
azoospermia.[23]
A mutation in the gene for the activin receptor ACVR1 results
in fibrodysplasia ossificans progressiva, a fatal disease that
causes muscle and soft tissue to gradually be replaced by
bone tissue.[24]
This condition is characterized by the formation of an extra
skeleton that produces immobilization and eventually death by
suffocation.[24]
The mutation in ACVR1 causes activin A, which normally acts
as an antagonist of the receptor and blocks osteogenesis
(bone growth), to behave as an agonist of the receptor and to
induce hyperactive bone growth.[24] On 2 September 2015,
Regeneron announced that they had developed an antibody for
activin A that effectively cures the disease in an animal model
of the condition.[25]
Mutations in the ACVR1 gene have also been linked to cancer,
especially diffuse intrinsic pontine glioma (DIPG).[26][27][28]
See also